Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Ketamine Infusion for Analgesia in the ED
NCT05518877Phase 4Completed
- Sponsor
- Summa Health
- Start
- Dec 2022
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in acute pain, sponsored by Summa Health. Started Dec 2022; status: completed.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05518877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05518877.